Myeloma cell lines have well-known responses to many TGF-β superfamily ligands.[15–17] Thus, they represent a possible model system to characterize receptor usage by GDF15, given that GDF15 activates one or both of the SMAD-pathways downstream of TGF-β superfamily type 1 receptors. Here, TGFB1 is linked to plasma cell myeloma.